首页> 外文期刊>Anaesthesia >Use of invasive placebos in research on local anaesthetic interventions
【24h】

Use of invasive placebos in research on local anaesthetic interventions

机译:侵入性安慰剂在局部麻醉干预研究中的应用

获取原文
获取原文并翻译 | 示例
           

摘要

Placebos play a vital role in clinical research, but their invasive use in the context of local anaesthetic blocks is controversial. We assessed whether recently published randomised controlled trials of local anaesthetic blocks risked harming control group patients in contravention of the Declaration of Helsinki. We developed the ‘SHAM’ (Serious Harm and Morbidity) scale to assess risk: grade 0?=?no risk (no intervention); grade 1?=?minimal risk (for example, skin allergy to dressing); grade 2?=?minor risk (for example, subcutaneous haematoma, infection); grade 3?=?moderate risk (with or without placebo injection) (for example, neuropraxia); and grade 4?=?major risk (such as blindness, pneumothorax, or liver laceration). Placebo interventions of the 59 included trials were given a SHAM grade. Nine hundred and nineteen patients in 31 studies, including six studies with 183 children, received an invasive placebo assessed as SHAM grade ≥?3. A high level of agreement (78%, κ?=?0.80, p?
机译:安慰剂在临床研究中起着至关重要的作用,但是在局部麻醉药阻滞的情况下,它们的侵入性使用引起争议。我们评估了最近发表的局部麻醉阻滞剂随机对照试验是否有违反《赫尔辛基宣言》的危险而伤害对照组患者。我们开发了“ SHAM”(严重危害和发病率)量表来评估风险:0级==无风险(无需干预); 1级=最小风险(例如,皮肤对敷料过敏); 2级=较小风险(例如皮下血肿,感染); 3级=中等风险(有或没有安慰剂注射)(例如神经失用); 4级==重大风险(例如失明,气胸或肝裂伤)。纳入的59项试验的安慰剂干预措施均为SHAM等级。 31项研究中的919名患者(包括针对183名儿童的6项研究)接受了SHAM≥3级评估的侵入性安慰剂。在评估者之间进行讨论后,对于0–4级SHAM,高水平的一致性(78%,κ= 0.80,p <0.001)增加到100%。超过一半的随机对照研究设计使对照组患者遭受严重或不可逆转的伤害。关于是否有理由使对照组患者遭受严重伤害的风险的辩论早该进行。

著录项

  • 来源
    《Anaesthesia》 |2011年第2期|84-91|共8页
  • 作者单位

    Anaesthetic Senior Registrar;

    Consultant Anaesthetist;

    Senior Consultant Anaesthetist Women’s and Children’s Hospital North Adelaide SA Australia;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号